Moss Gregory S. sold $325K of EVMN
Moss Gregory S. (Chief Business & Legal Officer) sold 14,223 shares of Evommune, Inc. (EVMN) at $22.83 ($0.32M total) on 2026-05-28 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosure provides a datapoint on insider liquidity/positioning, but the pre-arranged 10b5-1 plan reduces interpretability as a new negative signal.
Market read
Traders may treat this as low-signal sentiment noise rather than a fundamental catalyst.
What to watch
The filing doesn’t reveal whether the officer’s remaining holdings are being reduced via multiple planned trades; also consider whether other insiders/funds filed contemporaneous Form 4/13D/13G activity.
Background
This is an SEC Form 4 insider transaction disclosure for Evommune, Inc. (EVMN).
Ticker impact
Evommune officer sold 14,223 shares in an open-market transaction for ~$324.7K, disclosed via SEC Form 4 with a 10b5-1 plan.
Likely limited near-term impact; any effect is more sentiment/positioning than fundamentals.
Form 4 shows a scheduled 10b5-1 sale rather than discretionary selling, and the filing provides no new operating or deal catalyst.
Market effects
No clear sector read-through; this is company-specific insider activity.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can still coincide with weaker near-term expectations; monitor for additional sales or changes in trading patterns.
Key entities
- issuerEvommune, Inc.
Subject of the insider transaction disclosure (EVMN).
- insiderMoss Gregory S.
Chief Business & Legal Officer who sold shares under a 10b5-1 plan.
